[1]
Asif, S. et al. 2018. Posterior Reversible Leukoencephalopathy Syndrome in a patient after second dose of Rituximab for treatment of resistant Thrombotic Thrombocytopenic Purpura. Journal of Clinical Nephrology. 2, 1 (Feb. 2018), 001–004. DOI:https://doi.org/10.29328/journal.jcn.1001010.